Quarterly report pursuant to Section 13 or 15(d)

EARNINGS (LOSS) PER SHARE - Narrative (Details)

v3.22.2.2
EARNINGS (LOSS) PER SHARE - Narrative (Details) - USD ($)
$ in Thousands
1 Months Ended 6 Months Ended
Apr. 30, 2022
Jun. 30, 2022
Jun. 30, 2021
Aug. 09, 2021
Earnings Per Share, Diluted, by Common Class, Including Two Class Method [Line Items]        
Antidilutive securities excluded from computation of earnings per share (in shares)   51,164,060 43,090,513  
Super Voting Shares | NuLeaf        
Earnings Per Share, Diluted, by Common Class, Including Two Class Method [Line Items]        
Antidilutive securities excluded from computation of earnings per share (in shares) 888,880      
Super Voting Shares | Nature's Remedy        
Earnings Per Share, Diluted, by Common Class, Including Two Class Method [Line Items]        
Antidilutive securities excluded from computation of earnings per share (in shares)   3,291,885    
Super Voting Shares        
Earnings Per Share, Diluted, by Common Class, Including Two Class Method [Line Items]        
Common stock, issued (in shares)       149,000
Super Voting Shares | Nature's Remedy        
Earnings Per Share, Diluted, by Common Class, Including Two Class Method [Line Items]        
Equity issued   $ 5,000    
Multiple Voting Shares        
Earnings Per Share, Diluted, by Common Class, Including Two Class Method [Line Items]        
Common stock, outstanding (in shares)       4,000,000